Subarachnoid neurolytic block (L5–S1) and unilateral percutaneous cervical cordotomy in the treatment of pain secondary to pelvic malignant disease
| Autor: | Aldo Luzzani, Alberto Ischia, Stefano Ischia, Fabio Magon, Domenica Toscano |
|---|---|
| Rok vydání: | 1984 |
| Předmět: |
Adult
Male medicine.medical_specialty Percutaneous Genital Neoplasms Female government.form_of_government medicine.medical_treatment Punctures Subarachnoid Space Cordotomy medicine Humans Pelvis Neurolysis Aged Pelvic Neoplasms Rectal Neoplasms business.industry Urinary retention Palliative Care Neurolytic Block Nerve Block Sequela Middle Aged Pelvic cavity medicine.disease Surgery Anesthesiology and Pain Medicine medicine.anatomical_structure Urinary Bladder Neoplasms Neurology Anesthesia Colonic Neoplasms government Female Neurology (clinical) medicine.symptom business Follow-Up Studies |
| Zdroj: | Pain. 20:139-149 |
| ISSN: | 0304-3959 |
| DOI: | 10.1016/0304-3959(84)90095-2 |
| Popis: | The present study deals with the immediate and long-term results of subarachnoid neurolytic block (L 5 −S 1 ) with 7.5%, 10% and 15% concentrations of phenol in glycerine and/or unilateral percutaneous cervical cordotomy in 73 patients (follow-up in 56 patients) suffering from perineal, perineopelvisacral or pelvisacral pain secondary to malignant diseases of the pelvic cavity. Subarachnoid neurolytic block ( L 5 − S 1 ) produced satisfactory, long-lasting relief of perineal pain when the higher concentrations of phenol (10 and 15%) were used. The only sequela reported was urinary retention. Percutaneous cervical cordotomy used for the treatment of pelvisacral or predominantly unilateral perineal pain gave complete pain relief until death in 76.7% of patients, either alone (36.7%) or in conjunction with pharmacological therapy (40%). Analysis of the data enabled us to establish the respective indications for the two procedures and to identify those cases in which their use may be complementary. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|